Search This Blog

Tuesday, May 7, 2019

Allergan sees Q2 adjusted EPS $4.20-$4.40, consensus $4.20

Sees Q2 revenue $3.85B-$4B, consensus $3.87B.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)